Skip to the answer

Dornase Alfa Uses, Dosage, Side Effects and Interactions

Brand name
Pulmozyme

Pulmozyme is a brand of dornase alfa that comes as an inhalation solution (nebulizer).

Dornase alfa is an inhaled enzyme medicine used with standard therapies to help people with cystic fibrosis breathe better.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About Dornase AlfaType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Dornase Alfa in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Dornase alfa (Pulmozyme) is an inhaled enzyme that cuts up the DNA from broken-down white blood cells that makes cystic fibrosis mucus thick and sticky, helping the airways clear and lung function improve; used with standard CF treatments in children and adults, it has been a mainstay of daily CF care since about 1993 and is still available only as the brand. Most people tolerate it well; a hoarse or changed voice and a sore throat are what they notice most. Get medical help for a rash, swelling or trouble breathing (possible signs of an allergic reaction), or for chest pain or worsening shortness of breath.

Key Takeaways From the HelloPharmacist Team

  • Inhale it through a nebulizer once a day, or twice a day if prescribed, and use only a nebulizer type recommended for Pulmozyme.
  • Run it as its own treatment, never mixed or diluted with your other nebulizer medicines, since mixing can change how either drug works.
  • Keep up your airway clearance and other CF treatments, because this medicine works alongside them rather than replacing them.
  • Squeeze each ampule to check for leaks, skip any that looks cloudy or discolored, and use or discard the whole ampule once opened.

How we write and review this content: our editorial policy

Dornase Alfa by the Numbers

Strengths
1
in one form
Makers and packagers
1
Earliest FDA record
1993
Rank by Medicaid prescriptions
#675 of 1,682 drugs
More prescriptions than 59% of the 1,682 drugs we measure
42,474 prescriptions, Q1–Q4 2025

Patient Information Guide for Dornase Alfa

What It’s Used For

Dornase alfa is used for cystic fibrosis. These uses apply to Pulmozyme inhalation solution:

  • Pulmozyme is used with standard therapies to improve lung function in children and adults with cystic fibrosis (CF).
  • In CF patients with an FVC of 40% of predicted or higher, daily Pulmozyme has also been shown to reduce the risk of respiratory tract infections needing antibiotics by injection or IV.

How It Works

Dornase alfa is a lab-made version of a human enzyme called DNase I. It cuts up DNA. In CF, thick infected mucus holds a lot of DNA from broken-down white blood cells.

In lab studies, dornase alfa broke down this DNA in CF sputum and made it less thick and sticky. Thick mucus in the airways contributes to poorer lung function and infection flare-ups.

Drug Class

Drug Class

  • Recombinant Human Deoxyribonuclease 1
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Recombinant Human Deoxyribonuclease 1

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)

None listed for Dornase Alfa in the FDA’s index.

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)
  • Decreased Respiratory Secretion Viscosity

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Deoxyribonuclease I
  • Recombinant Proteins

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Mucolytics

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Pulmozyme is inhaled through a nebulizer, usually once a day. Some people may benefit from twice daily use.

Follow your prescriber's directions.

  • Use a recommended jet nebulizer with an air compressor, or a recommended vibrating mesh nebulizer.
  • The eRapid system is only for people who can use a mouthpiece, not those who need a mask.
  • Squeeze each ampule to check for leaks. Do not use cloudy or discolored solution.
  • Use or discard the entire ampule once opened.
  • Do not dilute it or mix it with other drugs in the nebulizer.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Cystic fibrosis lung function

Cystic fibrosis, patients who may benefit from twice daily administration Usual dose 2.5 mg (one single-dose ampule) inhaled twice a day

Good to know

Some patients may benefit from twice daily administration

Children and adults with cystic fibrosis Usual dose 2.5 mg (one single-dose ampule) inhaled once a day
  • 2.5 mg (one single-dose ampule) inhaled once daily using a recommended jet nebulizer connected to an air compressor system or via a vibrating mesh nebulizer

See the Full Dosing Instructions on DailyMed →

Side Effects

In clinical trials in people with CF, these were more common with Pulmozyme than with placebo:

Common side effects

  • Voice changes
  • Sore throat (pharyngitis)
  • Rash
  • Laryngitis (hoarse, irritated voice box)
  • Chest pain
  • Red, irritated eyes (conjunctivitis)
  • Runny or stuffy nose (rhinitis)
  • Fever
  • A drop in FVC of 10% or more

When to get medical help

  • Call your doctor if you have a rash, swelling or trouble breathing that could signal an allergic reaction.
  • Get medical help for chest pain or worsening shortness of breath.
  • Tell your care team if side effects are bothersome or do not go away.

Most reactions were mild and short-lived, and few people had to stop treatment. Report side effects to your doctor, Genentech at 1-888-835-2555, or FDA MedWatch.

Warnings and Precautions

The label lists no specific warnings or precautions. The key safety point is not to use it if you are allergic to it.

  • Use only recommended nebulizers.
  • Never mix it with other drugs in the nebulizer.

Interactions

The label says there are no clinically important drug-drug interactions.

  • Do not mix Pulmozyme with other drugs in the nebulizer. Mixing could change how Pulmozyme or the other drug works.

Interactions Listed in the FDA-Approved Label

From the Dornase Alfa prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Other drugs (drug-drug interactions)
    What happensAvailable data indicate there are no clinically important drug-drug interactions with PULMOZYME.
  • Other drugs mixed in the nebulizer
    What happensMixing PULMOZYME with other drugs could lead to adverse physicochemical and/or functional changes in PULMOZYME or the admixed compound.
    What to doDo not dilute or mix PULMOZYME with other drugs in the nebulizer.
Read the label’s full interactions text

7 DRUG INTERACTIONS Available data indicate there are no clinically important drug-drug interactions with PULMOZYME.

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use it if you are allergic to dornase alfa, Chinese Hamster Ovary cell products, or any ingredient in it.
  • Pregnancy: no adequate studies in pregnant women. Animal studies showed no fetal harm.
  • Breastfeeding: not known if it is in human milk. Discuss benefits and risks with your doctor.
  • Children: safety and effectiveness have been established in pediatric CF patients, including use supported in those under 5 years.
  • Older adults: too few people 65 and older were studied to know if they respond differently.

Half-Life and How Your Body Processes It

After inhalation, dornase alfa is measurable in sputum within 15 minutes. Levels fall by about two hours later. Inhaling it did not significantly raise blood levels above normal natural levels, and it did not build up in the blood with repeated use.

It is expected to be broken down by proteases (enzymes that digest proteins) in body fluids. An IV study suggested a half-life of 3 to 4 hours.

Storage

Store PULMOZYME ampules at a refrigerated temperature between 2°C to 8°C (36°F to 46°F) in their protective foil to protect from light and heat. Refrigerated in the protective foil pouch to protect from light and heat.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Dornase Alfa: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Dornase Alfa — the kind of thing our pharmacy team would talk through with you at the counter.

What is Pulmozyme (dornase alfa) used for?

It is used along with your other standard treatments to manage cystic fibrosis. It helps improve lung function. In people with an FVC of 40% of predicted or higher, daily use has also been shown to lower the risk of respiratory infections needing injected antibiotics.

How do I use Pulmozyme?

You inhale it as a mist through a recommended nebulizer, usually once a day. Some people may do better with twice daily use, so follow your prescriber's directions. Squeeze each ampule to check for leaks, and do not use it if it looks cloudy or discolored.

Can I mix Pulmozyme with my other nebulizer medicines?

No. Do not dilute it or mix it with other drugs in the nebulizer. Mixing could change how Pulmozyme or the other medicine works. The label says there are no clinically important drug interactions, but keep them separate.

What side effects should I expect?

The most common ones are voice changes, sore throat, rash, hoarseness, runny nose, pink eye, fever and chest pain. Most are mild and short-lived. Let your doctor know if they bother you or don't go away.

Is Pulmozyme safe during pregnancy or breastfeeding?

There are no adequate studies in pregnant women, but animal studies showed no harm to the fetus. It is not known if it passes into breast milk. Talk with your doctor to weigh the benefits and risks.

Can children use Pulmozyme?

Yes. Its safety and effectiveness have been established in children with cystic fibrosis. Your child's doctor will guide how to give it and which nebulizer to use.

Is dornase alfa available over the counter?

No. Dornase alfa is a prescription medicine: every dornase alfa product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was dornase alfa first available?

The earliest FDA record we hold for dornase alfa is from 1993: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when dornase alfa was first used.

What is the brand name of dornase alfa?

Dornase alfa is the generic name. Its brand name is Pulmozyme.

What is the generic name of Pulmozyme?

The generic name of Pulmozyme is dornase alfa. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is dornase alfa?

Dornase alfa belongs to the drug class Recombinant Human Deoxyribonuclease 1, its established pharmacologic class on the FDA label.

What strengths does dornase alfa come in?

Dornase alfa is listed in the FDA's National Drug Code Directory in these forms and strengths. Inhalation solution (nebulizer) (inhaled): 1 mg/mL. A listing does not mean every pharmacy stocks every strength.

How much does dornase alfa cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $53.22 per mL of the 1 mg/mL inhalation solution (nebulizer) of brand-name Pulmozyme as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a dornase alfa shortage?

No. Dornase alfa is not on the FDA's drug shortage list as of Nov 22, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the dornase alfa prescribing information (package insert)?

The full FDA-approved prescribing information for dornase alfa, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Genentech, Inc.'s, revised Dec 17, 2025, and links to it on DailyMed.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Dornase Alfa

Skip the scrolling. Ask in your own words and get an answer from Dornase Alfa’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Dornase Alfa’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Dornase Alfa on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Dornase Alfa Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Dornase Alfa Forms and Strengths (How It Comes)

Dornase Alfa comes in 1 dose form, the inhalation solution (nebulizer). Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Dornase Alfa inactive ingredients by manufacturer.

Inhalation solution (nebulizer)

Inhaled
Brands Pulmozyme
How this form is used
What it may be used for
  • Pulmozyme is used with standard therapies to improve lung function in children and adults with cystic fibrosis.
  • Pulmozyme daily use has been shown to reduce the risk of respiratory infections needing injected antibiotics in CF patients with an FVC of 40% of predicted or higher.
Important instructions
  • Pulmozyme is inhaled once daily in most people, and some may benefit from twice daily use.
  • Pulmozyme should be used with a recommended jet nebulizer with an air compressor or a recommended vibrating mesh nebulizer.
  • Pulmozyme ampules should be squeezed to check for leaks, and discarded if the solution is cloudy or discolored.
  • Do not dilute Pulmozyme or mix it with other drugs in the nebulizer.
Available strengths 1 strength
1 FDA-listed product record ⓘ

Dornase Alfa on the U.S. Market: Products, Makers and Brands

How Dornase Alfa appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

1 company lists 1 Dornase Alfa product record with the FDA, mostly as inhalation solution (nebulizer); the earliest marketing or approval year on record is 1993. The one brand name in the directory today is Pulmozyme; the rest are generics.

1
Dose forms ⓘ
1
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
1
FDA-listed product records ⓘ
1993
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Unfinished liquid (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

How Widely Dornase Alfa Is Used (Medicaid Data)

How many Dornase Alfa prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

42,474
Medicaid prescriptions filled (Q1–Q4 2025)
$194.3M paid by Medicaid, before rebates

How commonly is Dornase Alfa prescribed? Of the 1,682 medications we measure, Dornase Alfa ranks #675 by Medicaid prescriptions — more than 60% of them.

Where Dornase Alfa ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Dornase Alfa product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

dornase alfa 1 MG/ML Inhalation Solution

42,474 Medicaid prescriptions (Q1–Q4 2025) 100% of Dornase Alfa prescriptions shown $194.3M paid by Medicaid, before rebates ≈ $4,574 per prescription, before rebates

1 of 2 listed NDCs had Medicaid claims. RxNorm 310014

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 1 of the 2 listed Dornase Alfa NDCs had Medicaid claims.

Compare Dornase Alfa Products

A representative set of FDA-listed product records for Dornase Alfa — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Inhalation solution (nebulizer)
1 mg/mL Respiratory (inhalation) Genentech, Inc. BLA View NDC →

Showing 1 of 1 products — FDA National Drug Code Directory. See every product, package size and price: browse all 1 Dornase Alfa NDCs →

Dornase Alfa Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Dornase Alfa recalls since July 2021.

✅No Dornase Alfa recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Dornase Alfa in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
1
Strengths
1
Forms in current FDA listings
1 of 1
In current FDA listings No current FDA listing
Ingredient (IN) Dornase Alfa RxCUI 337623
  1. Dose form (SCDF) Inhalation Solution RxCUI 2108354
    In current FDA listings
    Its strength (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Dornase Alfa Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Dornase Alfa: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a strength to see how its price has changed since Nov 2023.

Strength

For brand-name Pulmozyme, the 1 mg/mL inhalation solution (nebulizer), pharmacies paid an average of $53.22 per mL as of Nov 18, 2026, up 3% from $51.66 a year earlier.

What pharmacies pay now
$53.22
per mL, as of Nov 18, 2026
Last 4 weeks
No change
from $53.22 on Oct 21, 2026
Last 12 months
Up 3%
from $51.66 on Nov 19, 2025
Lowest and highest since Nov 2023
$49.02 to $53.25
per mL

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Pulmozyme 1 mg/mL inhalation solution (nebulizer): the average pharmacy price per mL, the last survey of each month
MonthPharmacy price
Nov 2026$53.22
Oct 2026$53.22
Sep 2026$53.16
Aug 2026$53.08
Jul 2026$53.06
Jun 2026$53.12
May 2026$53.18
Apr 2026$53.25
Mar 2026$53.25
Feb 2026$53.25
Jan 2026$53.25
Dec 2025$51.70
Nov 2025$51.66
Oct 2025$51.62
Sep 2025$51.57
Aug 2025$51.56
Jul 2025$51.54
Jun 2025$51.49
May 2025$51.37
Apr 2025$51.66
Mar 2025$51.66
Feb 2025$51.66
Jan 2025$51.66
Dec 2024$50.16
Nov 2024$50.24
Oct 2024$50.27
Sep 2024$50.23
Aug 2024$50.29
Jul 2024$50.28
Jun 2024$50.26
May 2024$50.23
Apr 2024$50.49
Mar 2024$50.49
Feb 2024$50.49
Jan 2024$50.49
Dec 2023$49.02
Nov 2023$49.02
FormStrengthVersion What pharmacies pay
Inhalation solution (nebulizer) · Respiratory (inhalation) 1 mg/mL Pulmozyme (brand) $53.22 per mL NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Dornase Alfa Brand Names

Dornase Alfa has one brand name on record: Pulmozyme. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Pulmozyme

Who Makes Dornase Alfa: Manufacturers and Labelers

One company lists Dornase Alfa products with the FDA. By number of product records, the largest are Genentech, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Genentech, Inc. 1

Sources for This Dornase Alfa Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Dec 17, 2025, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Dornase Alfa.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
1
Finished products in the current FDA directory
1
Companies listing them (makers, repackagers, distributors)
1
FDA labeler codes behind them ⓘ
1
Linked representative label ⓘ
Genentech, Inc.
Linked label effective
Dec 17, 2025
Composite sections available
21
Linked SPL Set ID
d8c78a7e-ff99-48f3-8952-643ec2ea0f86
Linked SPL Document ID
71192c41-f7be-44b0-b232-1f74369239a0
Open the linked representative label on DailyMed ↗
NDC package records associated with this linked SPL 1

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Genentech, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →